Michael’s responsibilities at Evidera include scientific leadership and operational management of various initiatives in multiple therapeutic areas, including retrospective database analyses, clinical and economic models, strategic outcomes research plans and multimodal patient and physician surveys.
Michael specializes in various aspects of health services research, including applied health economics, policy analysis and program evaluation, and the management and analysis of health-related survey data. He has worked extensively with large national health surveys, such as the Medical Expenditure Panel Survey and the National Health Interview Survey, as well as with Medicare data, large health insurance claims and electronic health records databases and smaller surveys of targeted populations. He has also conceptualized and developed clinical-economic and budget impact models in a number of indications, including autoimmune disorders, cardiology, mental health and neurology, metabolic disorders, oncology, respiratory disorders, urinary disorders and women’s health.
Michael has published on the epidemiology, utilization and expenditure patterns of a number of health conditions and special populations as well as on the cost-effectiveness of competing therapies in peer-reviewed journals such as the American Journal of Public Health, Archives of Pediatrics and Adolescent Medicine, Blood Transfusion, Diabetology & Metabolic Syndrome, Health Economics, Ophthalmology, Pediatrics, Urology and Value in Health.
Prior to joining Evidera, Michael was on the faculty of Harvard School of Public Health, where he conducted publicly and privately funded research on health behavior decision making, as well as healthcare utilization and expenditures of special populations.
Michael has a doctorate in sociomedical sciences and a master’s degree in biostatistics, both from Columbia University in New York, as well as a bachelor’s degree in economics from the University of California, Los Angeles. He teaches an introductory health economics course at Drexel College of Medicine in Philadelphia and is an adjunct assistant professor at the Harvard School of Public Health, where he has developed and continues to teach courses in the analysis of secondary data. He is also an active referee for a number of economic and clinical journals, serves on the editorial board of ISRN Public Health and Neurosurgery and is a member of numerous public health and health economics associations.